Evidence map›Paper›PMID 34002041›Full record

ArticleBritish journal of cancer2021

Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.

Hilary A Robbins, Karine Alcala, Anthony J Swerdlow, Minouk J Schoemaker, Nick Wareham, Ruth C Travis, Philip A J Crosbie, Matthew Callister, David R Baldwin, Rebecca Landy and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hilary A RobbinsInternational Agency for Research on Cancer, Lyon, France. robbinsh@iarc.fr.ORCID http://orcid.org/0000-0001-6041-6866
Karine AlcalaInternational Agency for Research on Cancer, Lyon, France.ORCID http://orcid.org/0000-0003-2308-9880
Anthony J SwerdlowThe Institute of Cancer Research, London, UK.
Minouk J SchoemakerThe Institute of Cancer Research, London, UK.
Nick WarehamUniversity of Cambridge, Cambridge, UK.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Philip A J CrosbieUniversity of Manchester, Manchester, UK.
Matthew CallisterLeeds Teaching Hospitals, Leeds, UK.
David R BaldwinNottingham University Hospitals and University of Nottingham, Nottingham, UK.
Rebecca LandyDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mattias JohanssonInternational Agency for Research on Cancer, Lyon, France.ORCID http://orcid.org/0000-0002-3116-5081

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34002041
PMCPMC8292451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.